ENDRA Life Sciences (NDRA) Enterprise Value (2016 - 2026)

ENDRA Life Sciences has disclosed Enterprise Value across 11 years of filings, most recently posting -$356462.0 for Q1 2026.

• In Q1 2026, Enterprise Value rose 82.74% year-over-year to -$356462.0; the TTM figure through Mar 2026 stood at -$356462.0 (up 82.74% YoY), while the FY2025 annual figure was -$762365.0, up 76.39% from the prior year.
• Enterprise Value grew to -$356462.0 in Q1 2026, from -$762365.0 in the prior quarter.
• Over the last five years, Enterprise Value for NDRA reached as high as -$356462.0 in Q1 2026 and fell as low as -$11.3 million in Q2 2022.
• The 5-year median for Enterprise Value is -$3.2 million (2024), against an average of -$3.9 million.
• The widest YoY moves for Enterprise Value: up 83.27% in 2025, down 81.98% in 2025.
• A 5-year view of Enterprise Value shows it stood at -$4.9 million in 2022, then surged by 42.04% to -$2.8 million in 2023, then fell by 13.96% to -$3.2 million in 2024, then soared by 76.39% to -$762365.0 in 2025, then surged by 53.24% to -$356462.0 in 2026.
• According to Business Quant data, Enterprise Value over the past three periods registered -$356462.0, -$762365.0, and -$794036.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.